about
Differences in neural activation for object-directed grasping in chimpanzees and humansAccuracy Evaluation of a 3D Ultrasound-guided Biopsy SystemAnti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.Gallium and other agents in diseases of the lung.Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTPilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinomaWhole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.Molecular imaging in breast cancer.Gastrointestinal tract malignancies and positron emission tomography: an overview.Hyperspectral imaging and quantitative analysis for prostate cancer detection.Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images.Posterior bladder layering of excreted 18F-FDG on PET/CT.Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.Molecular imaging of advanced prostate cancer.(90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.[(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.PET Tracers Beyond FDG in Prostate Cancer.Radionuclide Therapies in Molecular Imaging and Precision Medicine.Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.Imaging of Prostate Cancer Using Fluciclovine.Involving users in the implementation of an imaging order entry system.Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?One possible future.The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care.Automatic 3D Segmentation of Ultrasound Images Using Atlas Registration and Statistical Texture Prior.A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the ProstateFasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.
P50
Q28681382-1C927FFC-5EA4-4BA3-B7B0-D0C1B7792BFAQ30445213-E3454EEE-5A62-41CF-A7C4-25D18F4BD942Q34139498-E0D44CBD-8F32-47AE-B933-725621685276Q34451031-C0B9DC10-D43D-49CB-9CBD-E951965C4BFEQ34522627-448EB740-F95A-40F4-A041-F15C5A1F49B0Q34726931-A63851D3-9AB3-4C64-B551-35111C396426Q34995973-E53A439F-A141-4E36-A0CF-81D202354F89Q35116088-5E650734-F47A-4F1C-84F4-5ADA8285BA92Q35586914-5FD68196-5DB9-4C7D-9BA4-D2E6A5AF43D6Q35874674-40D3FD1B-34D9-4820-B523-FB567AA60A5CQ36413983-EF3E8F8B-CC46-4000-8F08-6F368AF74E82Q36717489-11D0E568-4CFA-4A15-A750-26FAA20D7709Q36839766-237AF5A8-B0E2-4FCF-8C96-BD911D5991D2Q37052473-38355E24-DCDB-4CFF-8980-C5D86B2038B6Q37194767-7B89D16C-8C1E-4A8D-8D35-2BDEF6040C0DQ37268528-EF056EA7-C840-4C76-8F4F-BAA75B4FD477Q37779226-7191F956-7EDA-4522-8265-BE5EE5CD8768Q37906467-DD4510E9-7D9D-4572-9CB8-5D7FF8D947B2Q38011526-3EB80607-878B-4F35-B5BF-6D6D0F34773AQ38338661-AE274510-760A-4DC5-BDCA-9E6ADFC022E7Q38558360-99451CF1-75DD-44F8-8B07-580080B46547Q38843341-5B47CF13-05F6-484C-9656-66CEB0BCF6ECQ38884252-B220EF35-59C3-4886-A78A-00694500C547Q38970117-A1E11A7B-4487-4919-9C3B-DB9BEA376259Q38982759-80CF6B26-EA67-4131-8D85-D4B77CE756A9Q38983205-938331EB-5430-4543-B6B1-363BDD184BB6Q39003086-C599B327-919D-48D9-971A-CE9E5933A313Q39013376-97EFE17F-49F5-4D81-AB86-725C5FE791ADQ39077194-BA7B46DD-7BCA-4302-83A6-2F0B2F73B3F3Q39102136-381CC2F7-6C3E-413A-B122-B98160404414Q39155744-C36B63ED-EFDE-4090-8CC8-50C9A3CBF0E2Q39166086-BB24D80B-75DC-4347-9FAB-730513D87CF2Q39856954-D3C2654B-7667-47F3-B16C-345C75888995Q40085286-727E9763-CDFA-4490-86F3-14AC4A209548Q40093355-E6AD0ED7-70C5-4772-94AD-2C3FE71082ABQ40855234-1A3B7ECD-BCB3-4DC0-B07A-90376A5D7155Q41233626-08C5234D-1E07-45B3-9336-A3F4C2CE17D4Q41859260-4C73D5B6-40ED-434B-8F02-3D870B8CF135Q42202139-712B97F9-CE83-45EB-99C0-9BE7D1DCA349Q42229244-5488251F-0125-4C17-BD79-071A73DFBF3F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David M Schuster
@ast
David M Schuster
@en
David M Schuster
@es
David M Schuster
@nl
David M Schuster
@sl
type
label
David M Schuster
@ast
David M Schuster
@en
David M Schuster
@es
David M Schuster
@nl
David M Schuster
@sl
prefLabel
David M Schuster
@ast
David M Schuster
@en
David M Schuster
@es
David M Schuster
@nl
David M Schuster
@sl
P1053
D-6156-2011
P106
P108
P21
P31
P3829
P496
0000-0003-3077-742X